ProfileGDS4718 / 205399_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 58% 85% 38% 62% 46% 48% 50% 65% 55% 58% 59% 46% 47% 46% 64% 69% 50% 48% 48% 53% 60% 60% 60% 55% 45% 58% 49% 55% 45% 46% 62% 54% 41% 51% 45% 45% 70% 52% 90% 56% 46% 56% 43% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3255246
GSM549102patient 115, normal, homogenized [OPG study]6.0237858
GSM549104patient 119, normal, homogenized [OPG study]8.5121885
GSM549108patient 138, normal, homogenized [OPG study]4.9317938
GSM549119patient 077, normal, homogenized [OPG study]6.2275662
GSM549133patient 032, cancer, homogenized [OPG study]5.2630246
GSM549139patient 042, cancer, homogenized [OPG study]5.3828748
GSM549099patient 107, normal, homogenized [OPG study]5.5085550
GSM549109patient 139, normal, homogenized [OPG study]6.4901265
GSM549110patient 046, normal, homogenized [OPG study]5.8005755
GSM549114patient 063, normal, homogenized [OPG study]5.9313758
GSM549122patient 082, normal, homogenized [OPG study]6.0540959
GSM549134patient 033, cancer, homogenized [OPG study]5.2919746
GSM549136patient 036, cancer, homogenized [OPG study]5.3134747
GSM549140patient 044, cancer, homogenized [OPG study]5.2770846
GSM549111patient 047, normal, homogenized [OPG study]6.3884764
GSM549113patient 057, normal, homogenized [OPG study]6.7612169
GSM549132patient 031, cancer, homogenized [OPG study]5.5027850
GSM549137patient 038, cancer, homogenized [OPG study]5.3671548
GSM549142patient 047, cancer, homogenized [OPG study]5.5187548
GSM549100patient 110, normal, homogenized [OPG study]5.7171653
GSM549107patient 135, normal, homogenized [OPG study]6.1320560
GSM549115patient 068, normal, homogenized [OPG study]6.0715260
GSM549116patient 072, normal, homogenized [OPG study]6.1042160
GSM549120patient 078, normal, homogenized [OPG study]5.7991755
GSM549131patient 030, cancer, homogenized [OPG study]5.1751745
GSM549118patient 074, normal, homogenized [OPG study]6.0315858
GSM549129patient 027, cancer, homogenized [OPG study]5.4940349
GSM549123patient 088, normal, homogenized [OPG study]5.8139455
GSM549124patient 006, cancer, homogenized [OPG study]5.2748945
GSM549126patient 015, cancer, homogenized [OPG study]5.2555346
GSM549128patient 025, cancer, homogenized [OPG study]6.3258262
GSM549103patient 117, normal, homogenized [OPG study]5.8010654
GSM549117patient 073, normal, homogenized [OPG study]5.009241
GSM549138patient 041, cancer, homogenized [OPG study]5.5606551
GSM549141patient 045, cancer, homogenized [OPG study]5.1802845
GSM549130patient 028, cancer, homogenized [OPG study]5.2335345
GSM549101patient 111, normal, homogenized [OPG study]6.8927970
GSM549105patient 128, normal, homogenized [OPG study]5.6446352
GSM549106patient 134, normal, homogenized [OPG study]9.3407290
GSM549112patient 048, normal, homogenized [OPG study]5.8806256
GSM549125patient 011, cancer, homogenized [OPG study]5.325346
GSM549127patient 024, cancer, homogenized [OPG study]5.922956
GSM549135patient 035, cancer, homogenized [OPG study]5.0763543